Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05829356
What this trial is testing

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 159
Early research (Phase 1)Study completedNCT01109329
What this trial is testing

Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults

Who this might be right for
Human Metapneumovirus
National Institute of Allergy and Infectious Diseases (NIAID) 21
Large-scale testing (Phase 3)Study completedNCT00782431
What this trial is testing

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

Who this might be right for
Influenza
Alachua Government Services, Inc. 3,208
Early research (Phase 1)Study completedNCT05900154
What this trial is testing

Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Pfizer 128
Testing effectiveness (Phase 2)Looking for participantsNCT06879327
What this trial is testing

Infant Malaria Vaccine Schedule Optimization

Who this might be right for
Malaria Vaccines
PATH 964
Early research (Phase 1)Study completedNCT00308061
What this trial is testing

Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 40
Testing effectiveness (Phase 2)Looking for participantsNCT06895486
What this trial is testing

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

Who this might be right for
Poliomyelitis
PATH 675
Testing effectiveness (Phase 2)UnknownNCT03806686
What this trial is testing

Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers

Who this might be right for
Tuberculosis
Quratis Inc. 107
Large-scale testing (Phase 3)Study completedNCT00662870
What this trial is testing

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi 1,941
Early research (Phase 1)Study completedNCT00936429
What this trial is testing

Study of HBV-001 D1 in Healthy Adults

Who this might be right for
Dengue Fever
Hawaii Biotech, Inc. 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07133802
What this trial is testing

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Who this might be right for
Prevention of Influenza
Changchun BCHT Biotechnology Co. 6,680
Large-scale testing (Phase 3)Study completedNCT00452686
What this trial is testing

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Who this might be right for
DiphtheriaAcellular PertussisTetanus
GlaxoSmithKline 660
Large-scale testing (Phase 3)Study completedNCT02451969
What this trial is testing

Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly

Who this might be right for
Pneumococcal Infections
Sinovac Biotech Co., Ltd 1,760
Testing effectiveness (Phase 2)Active Not RecruitingNCT07199569
What this trial is testing

Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

Who this might be right for
Monkeypox (Mpox)
Bavarian Nordic 970
Early research (Phase 1)Study completedNCT01450280
What this trial is testing

Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS

Who this might be right for
Malaria
University of Oxford 24
Testing effectiveness (Phase 2)Study completedNCT00841646
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects

Who this might be right for
Prepandemic Influenza Vaccine
Novartis Vaccines 343
Testing effectiveness (Phase 2)Study completedNCT05630846
What this trial is testing

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Who this might be right for
Measles; Mumps; Rubella; ChickenpoxMeasles
GlaxoSmithKline 801
Early research (Phase 1)Study completedNCT01968083
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Study completedNCT05463354
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 410
Early research (Phase 1)Study completedNCT03475056
What this trial is testing

CAd3-Marburg Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Next Page